This bispecific antibody that specifically binds to human ErbB-1 and human c-Met comprises a first antigen-binding site that specifically binds to human ErbB-1 and a second antigen-binding site that specifically binds to human c-Met. It is capable of leading to a more pronounced inhibition of cancer cell proliferation and reducing the internalization of MET compared to the parent monospecific monovalent anti-c-Met antibody.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAND-L008 | Recombinant Anti-MET × Anti-EGFR Bispecific Antibody (Tandem Diabody) | FuncS, Promising therapeutic agent | Tandem Diabody |
There are currently no Customer reviews or questions for TRIAB-MZ007. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.